Data to support adenoma detection rate (ADR) as a measure of colonoscopy quality and cancer protection continue to emerge,1 along with evidence that behavior changes favorably when ADR is tracked.2 However, ADR can be a challenging metric to obtain, given the disparity in systems for pairing colonoscopy and pathology reports. Although several surrogate measures have been suggested as appropriate for quantifying quality (eg, ADR, polypectomy rate), the potential for gaming the system makes them less attractive,3 implying that the easiest metrics to count may not be the most useful ones.
Natural language processing (NLP) is a method of searching within text documents that has been used for obtaining multiple quality measures in endoscopy, especially the ADR (Table 1) . Since 2011, several institutions have developed customized in-house automated systems for quantifying ADR, advanced ADR, and site-specific ADR (proximal/distal), precluding the need for manual review. As providers of an effective but expensive and invasive technology, we endoscopists will soon be required to quantify colonoscopy quality for payers. 5 Although the potential for a system that uses artificial intelligence to track our services is no longer considered far-fetched, this vision must be tempered with consideration of what and how a metric is to be measured. There is a pressing need for a simple, yet accurate, method for moving toward an optimal system of tracking colonoscopy quality.
In this issue of Gastrointestinal Endoscopy, Raju and colleagues 6 report their experience with the computer application for ADR reporting (CAADRR). The CAADRR was developed to extract colonoscopy reports from existing endoscopy software and link them with associated pathology reports.
These reports were then processed with text mining to determine colonoscopy indication (ie, screening) and the findings of adenomas and sessile serrated polyps (SSPs). The authors validated this system against a manually curated data set and showed accuracy rates of 91.3% for detecting screening examinations, 99.4% for adenomas, and 100% for SSPs. These high rates are consistent with previous reports of single-center accuracy with the use of NLP. 7, 8, 9 and 10 From text mining of the reports, Raju et al were able to measure individual endoscopist's ADRs, which ranged from 22% to 62%, along with gender-stratified ADRs.
The authors are to be congratulated for creating a carefully constructed and sensible tracking system for several quality metrics. Although this work further establishes the ability of computer techniques to obtain a validated measurement of colonoscopy quality, it is not without limitations (as are previous efforts to advance NLP-based quality measurement of colonoscopies).6, 7, 8, 9 and 10 First, there appears to have been no differentiation between a training set and a test set, which increases both the potential for overtraining and the chance of less accurate performance when the method is applied to subsequent patient cohorts. Second, because traditional NLP was not used, the CAADRR system is unable to use context-specific term identification. As a result, the phrase "no … adenoma" would potentially count as an adenoma by the CAADRR system, whereas it would be recognized as a negated term by a complex NLP system; the misspelled word "adnoma" would be potentially missed with CAADRR but identified by NLP. Third, the CAADRR system has no method for finding adenomas 10 mm or larger, omitting the inclusion of this large subgroup of advanced adenomas from specific identification. The number of adenomas per colonoscopy, which may be a better quality metric than ADR, is also not possible to quantify in the CAADRR system. Furthermore, the accuracy of identifying a "screening" colonoscopy may be questioned because patients with rectal bleeding and a positive fecal blood test result were counted as "screening," whereas those with "family history of colorectal cancer" were excluded without specifically being first-degree relatives. Last, this is a single-center tool that was created on templated endoscopy software with a single pathology reporting system. Although the tool may work well on its "home court," the methods used to create it may not apply as well to other systems.
Despite advances made by several groups of investigators in automated measuring of selected quality determinations (Table 1) , there are and will likely remain several other determinants of colonoscopy quality that are not reflected in procedure note documentation. These include adequacy of luminal distention and examining the proximal sides of flexures, folds, and valves-techniques associated with lower adenoma miss rates.11 Although video recording of colonoscopies and randomly reviewing withdrawal techniques is a possibility,12 the practicality of implementing these practices may be too costly and time-consuming.
In 2015, technology pervades our professional life, with each clinical encounter systematically logged into the electronic medical record. The opportunity to use secondary data to improve the quality of health services and patient outcomes is apparent. However, we must temper our enthusiasm with reality. We must accept that not all patients for a provider or panels of patients among providers are the same. For example, a quality metric such as ADR must be coupled with adjustment for factors that affect risk for colorectal neoplasia (eg, age, gender, certain family histories, results of previous screening tests). An adjusted ADR would appropriately reduce unwanted variations caused by these factors, resulting in a better quality metric. Furthermore, today's best quality metric may not be tomorrow's. Mean adenoma number per screening colonoscopy may be a more robust, more "tamperproof" metric,13 so any technology used for quality monitoring must be adaptable to changing measures of quality. With the challenge of detecting SSPs, an SSP detection rate may be most indicative of high-quality colonoscopy, although variations in pathologic interpretation must be addressed definitively before further study.14 The optimal system will allow an endoscopist to perform a colonoscopy, create a colonoscopy report in an electronic format (endoscopy software or dictation), associate that report to a subsequent pathology report, extract meaningful quality measures (eg, ADR, ADR per procedure, advanced ADR, proximal ADR), adjust these rates for important covariates, and report these to the provider, a quality monitoring system (eg, the GI Quality Improvement Consortium), and the payer, all without any human review. A seamless process using NLP would both allow full transparency of care and encourage practice improvement. We are not too far from such a system, but before we can count a quality measure, we should know and accept the optimal measure(s) to count.
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